Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine

NCT03096444 is registered in ClinicalTrials.gov with Gil Yosipovitch as lead sponsor.

NCT NCT03096444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03096444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine
Lead sponsor
Gil Yosipovitch
Phase
Phase 2
Overall status
Terminated
Start date
May 23, 2017
Completion date
July 21, 2017
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pruritus